Latest news with #EuropeanMarkets
Yahoo
7 days ago
- Business
- Yahoo
Banco Santander, S.A. (SAN) Is A European Bank That's Not A Loser, Says Jim Cramer
We recently published . Banco Santander, S.A. (NYSE:SAN) is one of the stocks Jim Cramer recently discussed. Banco Santander, S.A. (NYSE:SAN) is one of Cramer's favorite European and banking stocks. The shares have gained 89% year-to-date, and the CNBC host had started to express his optimism in January, well before the recent share price movement. Banco Santander, S.A. (NYSE:SAN)'s stock has benefited from an overall growing interest in European markets due to uncertainty in America and from strong earnings. Cramer's previous comments have praised the firm's Ana Botin, and he kept the praise this time too: 'Okay so David, there's another bank, European bank, not a loser. . . .Banco Santander, Ana Botin, stock's up 88%. Uh Jamie's up 20%. Well, which would you rather own? A view of a large corporate office building, illuminated at night to show its power and reach. Earlier, he shed light on some of the driving factors behind the shares: 'Long time Cramer fave, Banco Santander, which is the second-best performing in the index (IBEX 35), up almost 52% for the year. Hey, by the way, Santander's American Deposit Receipts, SAN for you home gamers, are up almost 50% since we last spoke to Executive Chair Ana Botín back in October. Due to an embrace of technology and a knowledge of the consumer worldwide, Botín has built a powerhouse that's the envy of Europe. They just did a really smart transaction in Poland last week… Many reasons I'm partial to Santander, symbol, SAN.' While we acknowledge the potential of SAN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
14-07-2025
- Business
- Yahoo
European Undervalued Small Caps With Insider Action To Explore In July 2025
As European markets navigate a landscape marked by trade tensions and fluctuating economic indicators, the pan-European STOXX Europe 600 Index has recently shown resilience with a modest gain, despite the looming threat of higher U.S. tariffs on European goods. Amidst this backdrop, small-cap stocks present intriguing opportunities for investors seeking to capitalize on potential growth and insider actions that may indicate confidence in these companies' future prospects. Name PE PS Discount to Fair Value Value Rating Kitwave Group 13.0x 0.3x 45.28% ★★★★★☆ Stelrad Group 13.5x 0.8x 35.77% ★★★★★☆ Yubico 32.8x 4.7x 11.53% ★★★★☆☆ Renold 10.6x 0.7x 3.34% ★★★★☆☆ Seeing Machines NA 2.9x 44.11% ★★★★☆☆ A.G. BARR 19.2x 1.8x 47.03% ★★★☆☆☆ Oxford Instruments 44.7x 2.3x 6.80% ★★★☆☆☆ Fintel 44.0x 3.3x 41.94% ★★★☆☆☆ CVS Group 44.4x 1.3x 39.53% ★★★☆☆☆ Karnov Group 220.8x 4.7x 32.87% ★★★☆☆☆ Click here to see the full list of 59 stocks from our Undervalued European Small Caps With Insider Buying screener. Let's explore several standout options from the results in the screener. Simply Wall St Value Rating: ★★★★★★ Overview: Dotdigital Group specializes in providing data-driven omni-channel marketing automation solutions, with a market capitalization of approximately £0.26 billion. Operations: The company generates revenue primarily from its data-driven omni-channel marketing automation services, with the latest reported revenue at £82.59 million. Over recent periods, the gross profit margin has shown a decreasing trend, reaching 78.92% in December 2024 and further declining to 78.92% by July 2025. Operating expenses have been increasing steadily, impacting net income margins which have also seen a downward trajectory from previous highs. PE: 20.6x Dotdigital Group, a smaller European player in the tech sector, showcases potential for growth despite recent challenges. With an anticipated 11% annual earnings growth and insider confidence demonstrated through recent share purchases, the company appears poised for future expansion. The appointment of Tom Mullan as CFO, bringing extensive software industry experience, strengthens their leadership team. While external borrowing presents some risk, revenue guidance aligns with market expectations for 2025 after accounting for contract non-renewals impacting £0.7 million. Click here and access our complete valuation analysis report to understand the dynamics of dotdigital Group. Gain insights into dotdigital Group's historical performance by reviewing our past performance report. Simply Wall St Value Rating: ★★★★☆☆ Overview: Ariston Holding specializes in the production and sale of thermal comfort products, burners, and components, with a market capitalization of €3.5 billion. Operations: Thermal Comfort is the primary revenue driver, contributing significantly more than Burners and Components. The gross profit margin shows fluctuations, reaching 40.52% in late 2023 before declining to around 39.82% by mid-2025. Operating expenses have consistently increased over time, with General & Administrative Expenses being a major component of these costs. PE: 615.8x Ariston Holding, a European small company, has experienced insider confidence with recent share purchases made in Q1 2025. Despite high volatility in the past three months and reliance on external borrowing, the company is poised for growth with earnings expected to increase by 40.37% annually. However, profit margins have dipped from 6.1% last year to just 0.09%. Recent presentations at an Italian investment conference highlight Ariston's commitment to transparency and strategic communication with investors. Click here to discover the nuances of Ariston Holding with our detailed analytical valuation report. Review our historical performance report to gain insights into Ariston Holding's's past performance. Simply Wall St Value Rating: ★★★★☆☆ Overview: BioGaia is a Swedish biotechnology company specializing in the development and sale of probiotic products, with a market capitalization of approximately SEK 8.63 billion. Operations: BioGaia generates revenue primarily from its Pediatrics and Adult Health segments, with Pediatrics being the larger contributor. The company has experienced fluctuations in its net income margin, which was 34.36% as of September 30, 2023. Operating expenses are significant, with a notable portion allocated to Sales & Marketing and R&D activities. PE: 34.8x BioGaia, a European small-cap company, recently announced an extra dividend of SEK 4.95 per share alongside a regular dividend increase to SEK 1.95 per share at its AGM on May 7, 2025. Despite a slight dip in Q1 sales to SEK 366 million and net income falling to SEK 80 million from the previous year, insider confidence is evident with recent purchases by insiders. Earnings are projected to grow annually by over 17%, indicating potential for future value appreciation despite current funding risks due to reliance on external borrowing. Dive into the specifics of BioGaia here with our thorough valuation report. Learn about BioGaia's historical performance. Take a closer look at our Undervalued European Small Caps With Insider Buying list of 59 companies by clicking here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:DOTD BIT:ARIS and OM:BIOG B. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Finextra
11-07-2025
- Business
- Finextra
Nasdaq updates listing requirements for crypto assets
Nasdaq (Nasdaq: NDAQ) has announced updated listing requirements for underlying crypto assets, expanding the eligible currencies for Exchange Traded Products (ETPs) with crypto assets as underlying assets. 0 This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. 'We continue to see a growing demand to invest in ETPs with crypto assets as underlying assets and in our efforts to modernize our markets we are happy to now be able to enable issuers to issue more currencies through the new guidelines,' says Helena Wedin, Head of ETF and ETP, Nasdaq European Markets. ETPs with crypto assets as underlying assets must comply with the relevant Nasdaq Main Market Exchange Trades Notes Rulebook as well as the Nasdaq Nordic Crypto Guidelines. The guidelines complement the rulebooks and outline specific requirements that must be met to admit an ETP with crypto assets as underlying assets. One of the requirements has been that the underlying crypto asset must be included in the Nasdaq Crypto Index. This has now been revised to also include requirements on, among other, pricing, liquidity and trading availability of the underlying crypto asset, – opening for more crypto assets to be included. The revised guidelines are based on the existing requirements of the Nasdaq Crypto Index methodology and market practice.
Irish Times
09-07-2025
- Business
- Irish Times
European shares hit four week high
Banking and defence stocks aided European markets in closing at a four-week high on Wednesday. Investors awaited signs of progress on a trade accord between the United States and the European Union despite latest Trump threats. Dublin The Iseq All-Share index ended the session down 0.02 per cent to 11,480.17 as big caps Ryanair, Kerry Group and Glanbia led the losses. Airliner Ryanair fell 1.02 per cent to €24.34, while defensive stocks Kerry Group and Glanbia dropped 0.98 and 0.95 per cent respectively. READ MORE Homebuilders Glenveagh and Cairn Homes continued gains on Wednesday following news that the Government is looking at reducing the minimum apartment size in an effort to reduce the cost of construction. Glenveagh gained 2.13 per cent, rising to €1.82; and Cairn Homes added 1.9 per cent to reach €2.14. In a mixed day for the banks, with Permanent TSB shares struggling for direction as Bank of Ireland rose 1.46 per cent and AIB added 1.01 per cent. London The UK's FTSE 100 closed slightly higher on Wednesday, as investors monitored developments around U.S. tariff talks, while ad firm WPP slumped after it slashed its profit forecast. WPP's stock fell about 19 per cent, its biggest single-day percentage drop in more than three decades, as the company cut guidance after some big clients left, others cut spending and new business dried up in June. The stock weighed on the blue-chip FTSE 100, which closed up just 0.2 per cent. Copper prices at the London Metal Exchange fell, as those in the US traded at a premium, reflecting concerns that elevated prices across the Atlantic could suppress demand. Europe The pan-European STOXX 600 index rose 0.8 per cent to its highest close in nearly a month. Italy's bank-heavy benchmark jumped 1.6 per cent to its highest since 2007. Lender UniCredit was among the biggest gainers on the index, advancing 4.6 per cent to its highest since 2011. A broader gauge of euro zone banks climbed 2.7 per cent to its highest level since 2010, with French bank Société Générale also advancing 4 per cent The index tracking European defence companies gained 1.4 per cent to reach an all-time high, as German defence contractor Renk added 5 per cent following reports that company was considering selling its civilian industrial unit, or part of it. Shares in some European pharmaceutical companies fell, including Zealand Pharma falling 2.7 per cent and Novo Nordisk losing 1.5 per cent. Norwegian engineering group Kongsberg dropped 12 per cent as analysts said they saw some weaknesses in different parts of the results. On the bright side, EssilorLuxottica jumped 5.6 per cent following reports that Meta Platforms has acquired a nearly 3 per cent stake in the eyewear maker. New York Wall Street's main indexes ticked up in mid-afternoon trading on Wednesday as Nvidia rocketed to a $4 trillion (€3.4 trillion) valuation, while investors digested president Donald Trump's latest tariff salvo. Mr Trump ramped up his trade offensive on Tuesday, announcing a 50 per cent tariff on copper and vowing to slap long-threatened levies on semiconductors and pharmaceuticals. This came just a day after he jolted 14 trading partners with a fresh wave of tariff warnings, and said that at least seven new notices would drop later in the day. Markets' reaction have been relatively stable with analysts noting that investors have become used to Mr Trump's pattern of sabre-rattling on tariffs, and that the White House will potentially back down from its most aggressive threats. Among stocks, AES Corp rose after Bloomberg reported that the power provider was exploring options, including a sale. Health insurer UnitedHealth Group slipped after the Wall Street Journal reported that the US Department of Justice was investigating how the company deployed doctors and nurses to gather diagnoses that increased its Medicare payments. Boeing advanced as Susquehanna raised its price target after the planemaker on Tuesday reported that its airplane deliveries in June increased by 27 per cent on a yearly basis. – Additional reporting, Reuters, PA.
Yahoo
03-07-2025
- Business
- Yahoo
3 European Stocks That May Be Undervalued In July 2025
As the European markets show signs of resilience, with the STOXX Europe 600 Index climbing 1.32% amid easing geopolitical tensions and promises of economic stimulus, investors are keenly assessing opportunities in the region. Identifying undervalued stocks can be particularly appealing in such an environment, as these equities may offer potential for growth when market conditions stabilize further. Name Current Price Fair Value (Est) Discount (Est) Zaptec (OB:ZAP) NOK22.50 NOK44.90 49.9% Qt Group Oyj (HLSE:QTCOM) €57.55 €113.35 49.2% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.75 €110.26 49.4% Ion Beam Applications (ENXTBR:IBAB) €11.66 €22.99 49.3% innoscripta (XTRA:1INN) €99.30 €196.58 49.5% Honkarakenne Oyj (HLSE:HONBS) €2.70 €5.37 49.7% Green Oleo (BIT:GRN) €0.795 €1.57 49.2% Cavotec (OM:CCC) SEK17.00 SEK33.97 49.9% Archicom (WSE:ARH) PLN43.00 PLN84.73 49.2% ABO Energy GmbH KGaA (XTRA:AB9) €38.40 €76.54 49.8% Click here to see the full list of 180 stocks from our Undervalued European Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products across Spain, the European Union, OECD countries, and internationally with a market cap of €2.85 billion. Operations: Laboratorios Farmaceuticos Rovi generates revenue through the manufacturing, selling, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and internationally. Estimated Discount To Fair Value: 49.4% Laboratorios Farmaceuticos Rovi is trading at €55.75, significantly below its estimated fair value of €110.26, indicating it may be undervalued based on cash flows. Analysts agree the stock price could rise by 41.8%. With earnings forecast to grow 16.5% annually—outpacing the Spanish market's 5.5%—and revenue projected to increase at 8.2%, Rovi's financial outlook remains robust despite slower-than-significant growth expectations in both earnings and revenue metrics. Insights from our recent growth report point to a promising forecast for Laboratorios Farmaceuticos Rovi's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Laboratorios Farmaceuticos Rovi. Overview: Neste Oyj, with a market cap of €9.22 billion, operates in the production and distribution of renewable diesel and sustainable aviation fuel across Finland, other Nordic countries, the Baltic Rim, Europe, the United States, and internationally. Operations: The company's revenue segments include Oil Products (€12.10 billion), Renewable Products (€7.30 billion), and Marketing & Services (€4.51 billion). Estimated Discount To Fair Value: 19.6% Neste Oyj is trading at €12, below its estimated fair value of €14.92, reflecting a modest undervaluation based on discounted cash flow analysis. Despite recent volatility and high debt levels, the company is expected to achieve profitability within three years with earnings projected to grow significantly annually. Recent developments in renewable fuel technology with Chevron Lummus Global highlight potential future revenue streams, although recent index exclusion may impact investor sentiment. According our earnings growth report, there's an indication that Neste Oyj might be ready to expand. Click here to discover the nuances of Neste Oyj with our detailed financial health report. Overview: Andritz AG is a global provider of industrial machinery, equipment, and services across various continents including Europe, North America, South America, China, Asia, Africa, and Australia with a market cap of €5.99 billion. Operations: The company generates revenue from four main segments: Metals (€1.78 billion), Hydro Power (€1.61 billion), Pulp & Paper (€3.27 billion), and Environment & Energy (€1.52 billion). Estimated Discount To Fair Value: 48.3% Andritz AG, trading at €61.5, is significantly undervalued with an estimated fair value of €118.95 based on discounted cash flow analysis. Despite a decline in first-quarter sales and net income compared to the previous year, earnings are projected to grow 11.47% annually, outpacing the Austrian market's growth rate. However, its dividend yield of 4.23% is not fully supported by free cash flows, indicating potential sustainability concerns despite strong relative value against industry peers. Our comprehensive growth report raises the possibility that Andritz is poised for substantial financial growth. Unlock comprehensive insights into our analysis of Andritz stock in this financial health report. Investigate our full lineup of 180 Undervalued European Stocks Based On Cash Flows right here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:ROVI HLSE:NESTE and WBAG:ANDR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
